EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discrimination of Bipolar Disorder and Schizophrenia Patients Based on LC-HRMS Lipidomics

Milan R Janković, Nataša Avramović iD, Zoran Miladinović iD, Milka B Jadranin iD, Marija Takić iD, Gordana Krstić, Aleksandra Gavrilović, Čedo Miljević, Maja Pantović, Zorana Andrić iD, Savvas Radević iD, Danica Savić iD und 3 weitere

Metabolites · 12.01.2026 · 16 (1) · 69

DOI: 10.3390/metabo16010069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Metabolites, online erschienen am 12.01.2026. Verfasst von Milan R Janković und 14 weiteren Autor:innen. Beteiligte Einrichtung: University of Belgrade-Faculty of Chemistry, Studentski Trg 12-16, 11000 Belgrade, Serbia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Organization for the Prohibition of Chemical Weapons, Ministry of Science, Technological Development, and Innovation of the Republic of Serbia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Schizophrenia (SCH) and bipolar disorder (BD) share overlapping symptoms and genetic factors, making differential diagnosis challenging and often leading to misdiagnosis. This study aimed to identify potential lipid biomarkers of serum capable of distinguishing BD from SCH.

Methods

Lipid profiles of serum from 30 SCH and 31 BD patients were analyzed in triplicates using liquid chromatography–high-resolution mass spectrometry (LC-HRMS). Chemometric analysis was applied, including class and gender identifiers. Orthogonal partial least squares (OPLS) models with 1000 cross-validations were used to validate feature subsets.

Results

The chemometric analysis included the most relevant metabolites in the comparison between all samples of SCH and BD patients, identifying five key biomarkers (LPC 16:0, SM 33:1, SM 32:1, compound C30H58O3, and PC 30:0) with VIP scores > 1 for distinguishing BD from SCH. Gender-specific models revealed five biomarkers in males (SM 32:1, SM 33:1, PC 32:1, PC 30:0, and FA 16:1) and two in females (LPC 16:0 and C30H58O3). These biomarkers primarily belonged to glycerophospholipids (GPs) and sphingophospholipids (SPs).

Conclusions

Comparative lipid profiling between SCH and BD, including gender-specific subgroups, enabled identification of potential diagnosis-specific biomarkers. Elevated levels of GPs and SPs in SCH patients suggest lipid metabolism differences that may support improved diagnostic accuracy and personalized treatment strategies.

Schlagwörter

Stichwörter der Autor:innen

biomarkersbipolar disorderlipidomicsmass spectrometryschizophreniaserum

Autor:innen und Institutionen

  • University of Belgrade-Faculty of Chemistry, Studentski Trg 12-16, 11000 Belgrade, Serbia.
  • Institute of Medical Chemistry, University of Belgrade-Faculty of Medicine, Višegradska 26, 11000 Belgrade, Serbia.
  • Institute of General and Physical Chemistry, Studentski Trg 12-16, 11158 Belgrade, Serbia.
  • Department of Chemistry, University of Belgrade-Institute of Chemistry, Technology and Metallurgy, Njegoševa 12, 11000 Belgrade, Serbia.
  • Group for Nutrition and Metabolism, Center of Research Excellence for Nutrition and Metabolism, University of Belgrade-Institute for Medical Research, National Institute of Republic of Serbia, Tadeuša Košćuška 1, 11000…
  • Special Hospital for Psychiatric Diseases "Kovin", Cara Lazara 253, 26220 Kovin, Serbia.

ORCID-Profile: Nataša Avramović, Zoran Miladinović, Milka B Jadranin, Marija Takić, Zorana Andrić, Savvas Radević, Danica Savić, Vele Tešević

Förderung

  • Organization for the Prohibition of Chemical Weapons
  • Ministry of Science, Technological Development, and Innovation of the Republic of Serbia

Zitieren

APA

Janković, M. R., Avramović, N., Miladinović, Z., Jadranin, M. B., Takić, M., Krstić, G., Gavrilović, A., Miljević, Č., Pantović, M., Andrić, Z., Radević, S., Savić, D., Lekić, S., Tešević, V., & Mandić, B. (2026). Discrimination of Bipolar Disorder and Schizophrenia Patients Based on LC-HRMS Lipidomics. Metabolites, 16(1), 69. https://doi.org/10.3390/metabo16010069

Vancouver

Janković MR, Avramović N, Miladinović Z, Jadranin MB, Takić M, Krstić G, et al. Discrimination of Bipolar Disorder and Schizophrenia Patients Based on LC-HRMS Lipidomics. Metabolites. 2026;16(1):69. doi:10.3390/metabo16010069

BibTeX
@article{Jankovi2026,
  author = {Janković, Milan R and Avramović, Nataša and Miladinović, Zoran and Jadranin, Milka B and Takić, Marija and Krstić, Gordana and Gavrilović, Aleksandra and Miljević, Čedo and Pantović, Maja and Andrić, Zorana and Radević, Savvas and Savić, Danica and Lekić, Stefan and Tešević, Vele and Mandić, Boris},
  title = {Discrimination of Bipolar Disorder and Schizophrenia Patients Based on LC-HRMS Lipidomics},
  journal = {Metabolites},
  year = {2026},
  volume = {16},
  number = {1},
  pages = {69},
  doi = {10.3390/metabo16010069}
}
Kostenlos starten →